Array
(
[actionDate] => 2017-05-23
[displayText] => Reported by the Committee on Veterans' Affairs. H. Rept. 115-147.
[externalActionCode] => 5000
[description] => Introduced
)
Passed House
Array
(
[actionDate] => 2017-05-23
[displayText] => Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H4470)
[externalActionCode] => 8000
[description] => Passed House
)
Passed Senate
Array
(
[actionDate] => 2018-12-19
[displayText] => Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.
[externalActionCode] => 17000
[description] => Passed Senate
)
To President
Array
(
[actionDate] => 2018-12-21
[displayText] => Presented to President.
[externalActionCode] => 28000
[description] => To President
)
Became Law
Array
(
[actionDate] => 2018-12-21
[displayText] => Became Public Law No: 115-339.
[externalActionCode] => 36000
[description] => Became Law
)
[115th Congress Public Law 339]
[From the U.S. Government Publishing Office]
[[Page 132 STAT. 5036]]
Public Law 115-339
115th Congress
An Act
To direct the Secretary of Veterans Affairs to carry out a pilot program
to provide access to magnetic EEG/EKG-guided resonance therapy to
veterans. <<NOTE: Dec. 21, 2018 - [H.R. 1162]>>
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled, <<NOTE: No Hero Left
Untreated Act.>>
SECTION 1. SHORT TITLE.
This Act may be cited as the ``No Hero Left Untreated Act''.
SEC. 2. FINDINGS.
Congress finds the following:
(1) Magnetic EEG/EKG-guided resonance therapy has
successfully treated more than 400 veterans with post-traumatic
stress disorder, traumatic brain injury, military sexual trauma,
chronic pain, and opiate addiction.
(2) Recent clinical trials and randomized, placebo-
controlled, double-blind studies have produced promising
measurable outcomes in the evolution of magnetic EEG/EKG-guided
resonance therapy.
(3) The outcomes described in paragraph (2) have resulted in
escalating demand from returning members of the Armed Forces and
veterans who are seeking access to magnetic EEG/EKG-guided
resonance therapy.
(4) Congress recognizes the importance of initiating
innovative pilot programs that demonstrate the use and
effectiveness of new treatment options for post-traumatic stress
disorder, traumatic brain injury, military sexual trauma,
chronic pain, and opiate addiction.
SEC. 3. MAGNETIC EEG/EKG-GUIDED RESONANCE THERAPY PILOT PROGRAM.
(a) <<NOTE: Deadline.>> Pilot Program.--Commencing not later than
90 days after the date of the enactment of this Act, the Secretary of
Veterans Affairs shall carry out a pilot program to provide access to
magnetic EEG/EKG-guided resonance therapy to treat veterans suffering
from post-traumatic stress disorder, traumatic brain injury, military
sexual trauma, chronic pain, or opiate addiction.
(b) Locations.--The Secretary shall carry out the pilot program
under subsection (a) at not more than two facilities of the Department
of Veterans Affairs.
(c) Participants.--In carrying out the pilot program under
subsection (a), the Secretary shall provide access to magnetic EEG/EKG-
guided resonance therapy to not more than 50 veterans.
(d) Duration.--The Secretary shall carry out the pilot program under
subsection (a) for a 1-year period.
[[Page 132 STAT. 5037]]
(e) Report.--Not later than 90 days after the termination of the
pilot program under subsection (d), the Secretary shall submit to the
Committee on Veterans' Affairs of the Senate and the Committee on
Veterans' Affairs of the House of Representatives a report on the pilot
program.
(f) No Authorization of Appropriations.--No additional amounts are
authorized to be appropriated to carry out the requirements of this
section. Such requirements shall be carried out using amounts authorized
under provisions of law other than this section.
Approved December 21, 2018.
LEGISLATIVE HISTORY--H.R. 1162:
---------------------------------------------------------------------------
HOUSE REPORTS: No. 115-147 (Comm. on Veterans' Affairs).
CONGRESSIONAL RECORD:
Vol. 163 (2017):
May 23, considered and passed House.
Vol. 164 (2018):
Dec. 19, considered and passed
Senate.
<all>